Earnings 26 Jan: Lumibird SA (LBIRD.PA) EUR 23.30 intraday EURONEXT: guidance
LBIRD.PA stock trades at EUR 23.30 intraday as Lumibird SA prepares to report results on 26 Jan 2026. We see the upcoming earnings release as the immediate catalyst for price moves given the stock’s recent strength, a 1.30% intraday rise and a 50.00 PE sensitivity on expectations. Traders should watch guidance for Photonics orders and Medical unit margins ahead of the call.
Earnings preview: what LBIRD.PA stock must show
Lumibird must show revenue stability and clearer guidance for 2026 to justify current multiples. The market will focus on book-to-bill in Photonics and recurring revenue in Medical. We expect management commentary on backlog and order timing, which ties directly to short-term revenue recognition and margin outlook.
LBIRD.PA stock financials and valuation metrics
Lumibird trades at EUR 23.30 with EPS 0.48 and a PE 48.54, signaling premium valuation versus peers. The company reports market cap EUR 513102348.00 and price avg 50 EUR 20.80 and price avg 200 EUR 17.93, showing strong recovery from its year low EUR 7.40. These ratios mean investors pay for growth but must see margin recovery to justify multiples.
Meyka AI grade and LBIRD.PA stock forecast
Meyka AI rates LBIRD.PA with a score out of 100: 66.91 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects yearly EUR 31.79, implying +36.45% versus the current EUR 23.30. The quarterly model at EUR 26.49 implies +13.69%, while the monthly model at EUR 18.44 implies -20.86%. Forecasts are model-based projections and not guarantees.
Technicals and intraday LBIRD.PA stock action
Intraday momentum is modest: RSI 53.96, MACD histogram 0.06, ATR 0.63. Price sits between the Bollinger middle EUR 20.68 and upper band EUR 21.41, showing orderly trading. Volume 23,788.00 is near average 26,432.00, so we see measured buying ahead of earnings. Short-term support is EUR 22.70 and resistance near the year high EUR 23.90.
Risks and catalysts for LBIRD.PA stock
Key risks: slower Photonics orders, margin pressure in Medical, and higher net debt to EBITDA of 2.41. Catalysts include upward guidance, stronger recurring sales, or a major defence/space contract win. Watch cash conversion cycle and days sales outstanding at 113.22 days for working capital swings that could affect free cash flow.
Price targets and sector context for LBIRD.PA stock
We present three scenario targets in EUR: Conservative 26.50, Base 31.79 (Meyka yearly forecast), Bull 52.55 (3-year model). Compared with the Healthcare/Medical Diagnostics peers, Lumibird’s PE 48.54 exceeds the sector average ~34.64, reflecting higher growth expectations. Sector momentum is mixed, so earnings clarity is needed to close the valuation gap.
Final Thoughts
LBIRD.PA stock is trading at EUR 23.30 intraday on EURONEXT with earnings due 26 Jan 2026, and the report is likely to set the tone for near-term performance. Our view balances a premium current PE of 48.54 with growth signals in cash flow and a healthy current ratio 2.61. Meyka AI’s forecast model projects EUR 31.79 for the year, an implied +36.45% from today. That projection is model-based and not a guarantee. Short-term traders should focus on guidance and book-to-bill; longer-term investors should weigh debt metrics and free cash flow yield. We list pragmatic price targets: EUR 26.50 conservative, EUR 31.79 base, EUR 52.55 bullish. Use the earnings call to confirm revenue quality before adjusting positions. Meyka AI provides this AI-powered market analysis platform data for context; these grades and forecasts are informational, not investment advice.
FAQs
When does Lumibird report earnings and why does it matter for LBIRD.PA stock?
Lumibird reports on 26 Jan 2026. The earnings release matters because management guidance on Photonics orders and Medical margins will directly affect LBIRD.PA stock near-term and can alter valuation given the current PE 48.54.
What are the key valuation and cash metrics to watch for LBIRD.PA stock?
Watch PE 48.54, free cash flow yield 1.00%, debt to equity 0.85, and days sales outstanding 113.22. These metrics reveal valuation premium and working capital risks that can affect LBIRD.PA stock performance.
What is Meyka AI’s price outlook for LBIRD.PA stock?
Meyka AI’s forecast model projects a yearly target EUR 31.79, implying +36.45% from EUR 23.30. Forecasts are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
